CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 26, 2017	Mar. 27, 2016
Cash flows from operating activities:
Net cash provided by operating activities	$ 159,939	$ 41,131
Cash flows from investing activities:
Capital expenditures	(23,967)	(39,011)
Origination of finance receivables	(844,692)	(815,697)
Collections on finance receivables	781,154	771,910
Other	52	95
Net cash used by investing activities	(87,453)	(82,703)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	497,406	1,193,396
Repayments of medium-term notes	(400,000)	(450,000)
Repayments of securitization debt	(111,359)	(173,363)
Borrowings of asset-backed commercial paper	305,209	5,814
Repayments from Issuance of Asset-Backed Commercial Paper	29,383	15,740
Net decrease in credit facilities and unsecured commercial paper	(101,702)	(331,090)
Net change in restricted cash	(23,132)	(4,282)
Dividends paid	(64,611)	(64,457)
Purchase of common stock for treasury	(79,753)	(150,369)
Excess tax benefits from share-based payments	0	110
Issuance of common stock under employee stock option plans	7,336	276
Net cash provided by financing activities	11	10,295
Effect of exchange rate changes on cash and cash equivalents	7,219	3,081
Net increase (decrease) in cash and cash equivalents	79,716	(28,196)
Cash and cash equivalents:
Cash and cash equivalents—beginning of period	759,984	722,209
Net increase in cash and cash equivalents	79,716	(28,196)
Cash and cash equivalents—end of period	$ 839,700	$ 694,013